How much revenue does Radient Technologies make?

Radient Technologies reported 3.62 million CAD in revenue for fiscal year 2022, up 45.5% from 2.49 million CAD in fiscal year 2021. In Q3 2023 revenue was 1.03 million CAD.

What companies are similar to Radient Technologies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Genocea Biosciences, Inc. (GNCAQ), Imagenetix, Inc. (IAGX), Better Therapeutics, Inc. (BTTX), Interpharm Holdings, Inc. (IPAH).

Radient Technologies Inc. (RDDTF) Stock

About Radient Technologies Inc.

Radient Technologies Inc. engages in the cannabinoids business in Canada. It is also involved in online casino and real-money gaming opportunity activities. In addition, the company offers in-depth reviews, legal and safety insights, and exclusive offers, as well as highlights top operators for online casinos. Radient Technologies Inc. is based in Edmonton, Canada.

At a glance

Radient Technologies reported revenue of 3.62 million CAD for fiscal year 2022, up 45.5% from fiscal year 2021, and net income of -12.93 million CAD. In Q3 2023 (the quarter ended December 31, 2022) revenue was 1.03 million CAD, down 34.7% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.